Nuwellis, Inc. (NUWE)

Market Cap	5.87M
Revenue (ttm)	8.54M
Net Income (ttm)	-14.53M
Shares Out	1.21M
EPS (ttm)	-83.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,719
Open	4.81
Previous Close	4.80
Day's Range	4.81 - 5.10
52-Week Range	4.52 - 185.00
Beta	0.28
Analysts	Buy
Price Target	22.44 (+361.73%)
Earnings Date	May 8, 2023

About NUWE

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 70
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE

Financial Performance

In 2022, Nuwellis's revenue was $8.54 million, an increase of 7.85% compared to the previous year's $7.92 million. Losses were -$14.53 million, -25.72% less than in 2021.

Analyst Forecast

According to 9 analysts, the average rating for NUWE stock is "Buy." The 12-month stock price forecast is $22.44, which is an increase of 361.73% from the latest price.

Price Target

$22.44

(361.73% upside)

Analyst Consensus: Buy